Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health

FDA Classifies Medtronic Voluntary February Recall For Intrepid™ Intervertebral Body Fusion Device As Class II

Medtronic, Inc. (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has classified its voluntary recall action of the Intrepid™ Intervertebral Body Fusion Device as a Class II recall. Medtronic initiated a voluntary recall of the product on February 6, 2009, and communicated the risk to physicians and hospitals. As of the date of this news release, all unused product has been retrieved and Medtronic has received confirmation of notification from all affected physicians and hospitals.

Only Drop-In Needle Exchange Center In Minnesota Closes Due To Lack Of Funding

Minnesota"s only storefront needle exchange drop-in center, called Access Works!, "fell victim to economic hard times and federal anti-drug policies" and ended its program last week after 13 years, the Minnesota Independent reports. The program "traded used needles for clean ones, conducted HIV and Hepatitis C testing, taught overdose prevention, held support groups and connected users with chemical dependency treatment experts," according to the Independent. Federal funding cannot be used to administer needles for such programs, Lauri Wollner, executive director of the program said. She added, "The federal ban has had a long-term impact. We spend almost $40,000 a year on needles and about $5,000 a year on disposal (of used needles)." Private donations also have been down, she said. While the ban on the use of federal funding for needle exchange is being revisited by Congress, "local needle-exchange activists say it is doubtful that congressional action will be able to save the struggling organization," the article states (Birkey, 8/3).